IN RE MDL 2700 GENENTECH HERCEPTIN (TRASTUZUMAB)

No. 19-5035.

960 F.3d 1210 (2020)

IN RE: MDL 2700 GENENTECH HERCEPTIN (TRASTUZUMAB) MARKETING AND SALES PRACTICE LITIGATION. Tulsa Cancer Institute, PLLC, an Oklahoma Professional Limited Liability Company, n/k/a Oklahoma Cancer Specialists Management Company, LLC; Oklahoma Oncology & Hematology, Inc., an Oklahoma Corporation, d/b/a Cancer Care Associates; State of Oklahoma ex rel. Board of Regent for the State of Oklahoma; Florida Cancer Specialists, P.L., a Florida Professional Limited Liability; Hematology-Oncology Associates of Central New York, P.C., a New York Professional Corporation; Virginia Cancer Institute, a Virginia Commonwealth Professional Corporation; Tennessee Oncology, PLLC, a Tennessee Professional Limited Liability Corporation; North Shore Hematology Oncology Associates, P.C., a New York Professional Corporation; Texas Oncology, P.A., a Texas Professional Association; Cancer Care Network of South Texas, P.A.; Virginia Oncology Associates, P.C.; Minnesota Oncology Hematology, P.A.; Comanche County Memorial Hospital, on behalf of itself and all others similarly situated; Northwest Cancer Specialists, P.C., an Oregon professional corporation, d/b/a Compass Oncology; Oncology and Hematology Associates of Southwest Virginia, Inc., d/b/a Blue Ridge Cancer Care; Shenandoah Oncology, PC; Plaintiffs-Appellants, v. Genentech, Inc., a California Corporation, Defendant-Appellee, and Roche Holding AG; Roche Holding Ltd.; Roche Holdings, Inc., Defendants. American Medical Association; Oklahoma State Medical Association; Public Justice, P.C.; Chamber of Commerce of the United States of America; Pharmaceutical Research And Manufacturers of America; National Association of Manufacturers; Biotechnology Innovation Organization; Product Liability Advisory Council, Inc., Amici Curiae.

United States Court of Appeals, Tenth Circuit.

Filed May 29, 2020.


Attorney(s) appearing for the Case

Matthew W.H. Wessler , Gupta Wessler, Washington, DC ( David L. Bryant , Amelia A. Fogleman , Steven J. Adams , Adam C. Doverspike , James Wesley Scott Pebsworth , GableGotwals, Tulsa, Oklahoma, attorneys for Appellants Cancer Care Network of South Texas, P.A., Florida Cancer Specialists, P.L. Hematology-Oncology Associates of Central New York, P.C., Minnesota Oncology Hematology, P.A., North Shore Hematology-Oncology Associates, P.C., Northwest Cancer Specialists, P.C.; Oklahoma Oncology & Hematology, Inc., Oncology and Hematology Associates of Southwest Virginia, Inc., Shenandoah Oncology, PC, Tennessee Oncology, PLLC, Texas Oncology, P.A., Tulsa Cancer Institute, PLLC (now known as Oklahoma Cancer Specialists Management Company, LLC), State of Oklahoma ex rel. Board of Regents for the State of Oklahoma, Virginia Cancer Institute Inc., Virginia Oncology Associates, P.C.; James D. Sill , Matthew J. Sill , Kathryn Eidson Griffin , Tara Tabatabaie , Christopher J. Bergin , Simone Fulmer , Fulmer Sill PLC, Oklahoma City, Oklahoma, attorneys for Appellant Comanche County Memorial Hospital; and Janaki Hannah Nair , Elias Meginnes & Seghetti, P.C., Peoria, Illinois, attorneys for Appellant, Oncology-Hematology Associates of Central Illinois, P.C., with him on the briefs), appearing for Appellants.

Alicia J. Donahue , Shook, Hardy & Bacon, L.L.P., San Francisco, California ( Paul W. Schmidt , Covington & Burling LLP, New York, New York; James P. Muehlberger , Shook, Hardy & Bacon, L.L.P., Kansas City, Missouri; Emily Ullman , Covington & Burling LLP, Washington, DC; and William W. O'Connor , Hall, Estill, Hardwick, Gable, Golden & Nelson, P.C., Tulsa, Oklahoma, with her on the briefs), appearing for Appellees.

Jack R. Bierig and Catherine M. Masters , Schiff Hardin LLP, Chicago, Illinois, filed a brief for Amici Curiae American Medical Association and Oklahoma State Medical Association.

Leah M. Nicholls , Public Justice, P.C., Washington, DC, filed a brief for Amicus Curiae Public Justice, P.C.

K. Lee Marshall , Bryan Cave Leighton Paisner LLP, San Francisco, California; Timothy J. Hasken and Samuel E. Hofmeier . Bryan Cave Leighton Paisner LLP, St. Louis, Missouri, filed a brief for Amici Curiae Pharmaceutical Research and Manufacturers of America, National Association of Manufacturers, and Biotechnology Innovation Organization.

Daryl Joseffer and Tara S. Morrissey , United States Chamber Litigation Center, Washington, DC; Jeremy M. Bylund , Jeffrey S. Bucholtz , Marisa C. Maleck , and Gabriel Krimm , King & Spalding LLP, Washington, DC, filed a brief for Amicus Curiae Chamber of Commerce of the United States of America.

Galen D. Bellamy , Meghan Frei Berglind , and Eric L. Robertson , Wheeler Trigg O'Donnell LLP, Denver, Colorado, filed a brief for Amicus Curiae Product Liability Advisory Council, Inc.

Before BRISCOE, McHUGH, and MORITZ, Circuit Judges.


This appeal arises from a group of fourteen diversity cases that were consolidated by the Judicial Panel on Multidistrict Litigation and transferred to the Northern District of Oklahoma. The plaintiffs in all fourteen cases are cancer treatment providers who purchased multi-dose vials of Herceptin, a breast cancer drug, from...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases